<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01868230</url>
  </required_header>
  <id_info>
    <org_study_id>1R01DK097011-01A1</org_study_id>
    <secondary_id>1R01DK097011-01A1</secondary_id>
    <nct_id>NCT01868230</nct_id>
  </id_info>
  <brief_title>Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women</brief_title>
  <official_title>Proyecto Mama: Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Massachusetts, Amherst</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Massachusetts, Amherst</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal of this randomized controlled trial is to test the efficacy of a culturally&#xD;
      and linguistically modified, individually tailored lifestyle intervention to reduce excess&#xD;
      gestational weight gain (GWG), increase postpartum weight loss, and improve maternal&#xD;
      metabolic status among overweight/obese Hispanic women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall goal of this randomized controlled trial is to test the efficacy of a culturally&#xD;
      and linguistically modified, individually tailored lifestyle intervention to reduce excess&#xD;
      gestational weight gain (GWG), increase postpartum weight loss, and improve maternal&#xD;
      metabolic status among overweight/obese Hispanic women. Specific aims are to evaluate the&#xD;
      impact of the intervention on 1) GWG and postpartum weight loss, 2) pregnancy and postpartum&#xD;
      biomarkers of insulin resistance (i.e., glucose, insulin, HbA1c, HOMA, leptin, adiponectin),&#xD;
      3) postpartum biomarkers of cardiovascular risk (i.e., blood lipids, blood pressure), 4)&#xD;
      offspring outcomes (i.e., anthropometric measures and biomarkers of insulin resistance), and&#xD;
      5) to evaluate the cost-effectiveness of the intervention per average incremental improvement&#xD;
      in the outcome variables. Overweight/obese Hispanic women will be recruited in early&#xD;
      pregnancy (around 10 wks gestation) and randomly assigned to a Lifestyle Intervention (n=150)&#xD;
      or a Comparison Health and Wellness (control) Intervention (n=150). The intervention will&#xD;
      utilize exercise (R01NR011295) and dietary intervention materials (R18DK067549) culturally&#xD;
      adapted for Hispanics and shown to be efficacious in our previous controlled trials in this&#xD;
      ethnic group. Multimodal contacts (i.e., in-person, telephone counseling, and mailed&#xD;
      print-based materials) will be used to deliver the intervention during pregnancy (~12 wks&#xD;
      gestation to delivery) continuing into postpartum (~6 wks to 6 mos postpartum); follow-up&#xD;
      will continue for one year postpartum. Targets of the intervention are to achieve Institute&#xD;
      of Medicine Guidelines for GWG and postpartum weight loss; ACOG guidelines for physical&#xD;
      activity through increasing walking and developing a more active lifestyle; and reduction in&#xD;
      total calories by following a balanced healthy diet in compliance with American Diabetes&#xD;
      Association guidelines. The intervention draws from Social Cognitive Theory and the&#xD;
      Transtheoretical Model and includes strategies for partner and/or family support to address&#xD;
      the specific social, cultural, and economic challenges faced by underserved Hispanic women.&#xD;
      Measures of compliance will include actigraphs and Hispanic food frequency questionnaires.&#xD;
      The proposed project builds upon the expertise of the investigative team in conducting&#xD;
      randomized controlled trials of exercise interventions among Hispanic pregnant women (R01&#xD;
      DK074876) and dietary interventions among low-income Hispanics with type 2 diabetes (R18&#xD;
      DK0658850) and can readily be translated into clinical practice in underserved and minority&#xD;
      populations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">July 2018</completion_date>
  <primary_completion_date type="Actual">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin Resistance</measure>
    <time_frame>10 weeks gestation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin Resistance</measure>
    <time_frame>24 weeks gestation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin Resistance</measure>
    <time_frame>34 weeks gestation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin Resistance</measure>
    <time_frame>6 weeks postpartum</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin Resistance</measure>
    <time_frame>6 months postpartum</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin Resistance</measure>
    <time_frame>12 months postpartum</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">232</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stage-matched physical activity and diet intervention materials and health education.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle Intervention</intervention_name>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hispanic women&#xD;
&#xD;
          -  Overweight or obese before pregnancy (BMI &gt;25 kg/m2)&#xD;
&#xD;
          -  16-45 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of type 2 diabetes, heart disease, or chronic renal disease&#xD;
&#xD;
          -  contraindications to participation in moderate physical activity or to a&#xD;
             low-fat/high-fiber diet (e.g., Crohn's disease, ulcerative colitis)&#xD;
&#xD;
          -  inability to read English or Spanish at a 6th grade level&#xD;
&#xD;
          -  &gt;20 wks gestation&#xD;
&#xD;
          -  current medications which adversely influence glucose tolerance&#xD;
&#xD;
          -  not planning to continue to term or deliver at the study site&#xD;
&#xD;
          -  pregnant with twins or triplets&#xD;
&#xD;
          -  preterm birth (&lt;34 wks), a miscarriage, or a still birth after enrollment or a&#xD;
             stillbirth&#xD;
&#xD;
          -  women who become pregnant again in the year following delivery will be censored at the&#xD;
             time of their positive pregnancy test&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa Chasan-Taber, ScD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Massachusetts, Amherst</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>May 29, 2013</study_first_submitted>
  <study_first_submitted_qc>June 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2013</study_first_posted>
  <last_update_submitted>December 14, 2020</last_update_submitted>
  <last_update_submitted_qc>December 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Massachusetts, Amherst</investigator_affiliation>
    <investigator_full_name>Lisa Chasan-Taber</investigator_full_name>
    <investigator_title>Professor of Epidemiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

